APA

Kalayjian R. C., Machekano R. N., Rizk N., Robbins G. K., Gandhi R. T., Rodriguez B. A., Pollard R. B., Lederman M. M. & Landay A. (20100525). Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy. : The Journal of infectious diseases.

Chicago

Kalayjian Robert C, Machekano Rhoderick N, Rizk Nesrine, Robbins Gregory K, Gandhi Rajesh T, Rodriguez Benigno A, Pollard Richard B, Lederman Michael M and Landay Alan. 20100525. Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy. : The Journal of infectious diseases.

Harvard

Kalayjian R. C., Machekano R. N., Rizk N., Robbins G. K., Gandhi R. T., Rodriguez B. A., Pollard R. B., Lederman M. M. and Landay A. (20100525). Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy. : The Journal of infectious diseases.

MLA

Kalayjian Robert C, Machekano Rhoderick N, Rizk Nesrine, Robbins Gregory K, Gandhi Rajesh T, Rodriguez Benigno A, Pollard Richard B, Lederman Michael M and Landay Alan. Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy. : The Journal of infectious diseases. 20100525.